Scientific Name: Zanamivir
Brand Name: Relenza
Company Owner: Glaxosmithkline
Mechanism Of Action The proposed mechanism of action of zanamivir is via inhibition of influenza virus neuraminidase with the possibility of alteration of virus particle aggregation and release. By binding and inhibiting the neuraminidase protein, the drug renders the influenza virus unable to escape its host cell and infect others.
Description of the Drug: Zanamivir is a neuraminidase inhibitor used to treat influenza A and B.
Protein Data Bank:
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00558